The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: ejaculoid XXTREME and stimuloid II

    The FDA found that these dietary supplements contain sulfoaildenafil, similar to sildenafil (Viagra).

    The inclusion of sulfoaildenafil as anĀ  active ingredient is not FDA-approved, making these products unapproved drugs.

    Neither sulfoaildenafil nor sildenafil are listed on the product labels. These drugs may interact with nitrates found in drugs such as nitroglycerin and lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

    The bottom line?

    Customers who have ejaculoid XXTREME and stimuloid II in their possession should stop using them and contact their physician if they experience any problems that may be related to taking these products.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

    7/30/10 18:44 JR

    Leave a Comment

    You must be logged in to post a comment.